We perform antimicrobial product formulation, physical/chemical characterization (including stability) and efficacy testing. We have helped develop, characterize and test disinfectant products that are effective against bacteria, fungi and viruses under current Good Laboratory Practices. In addition to regular microbial testing, we also formulate traditional and novel antibiotics, antivirals and antifungals for infection prevention and reduction of systemic side effects. We developed a colon-targeted delivery for treatment of diseases such as C. difficile infection and inflammatory bowel diseases (IBD) and increased circulation for better pharmacokinetics and pharmacodynamics (PK/PD). We also design and develop antimicrobials that can be triggered release due to light, moisture, pH, enzymes, etc.